Correction to HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) in HLA‐B*58:01 carriers in Korean population; A multicenter cross‐sectional case‐control study
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmune Cell Function and Interaction · Urticaria and Related Conditions · Eosinophilic Disorders and Syndromes
M. Y. Kim, J. Yun, D. Y. Kang, T. H. Kim, M. K. Oh, S. Lee, et al. HLA‐A* 24: 02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B* 58: 01 carriers in a Korean population; a multicenter cross‐sectional case‐control study. Clin Transl Allergy. 2022 Sep 15;12(9):e12193.
This article [1] was published with a technical error in Figure 2, a size of bars in the allopurinol‐tolerant controls. The authors have re‐examined the data and confirmed that this correction would not have resulted in any alteration to the results or conclusion of the paper. The figure 2 should be shown as below.